Salati, S., Salvestrini, V., Carretta, C., Genovese, E., Rontauroli, S., Zini, R., . . . Manfredini, R. (2017). Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells. Oncotarget.

Salati, Simona, et al. "Deregulated Expression of MiR-29a-3p, MiR-494-3p and MiR-660-5p Affects Sensitivity to Tyrosine Kinase Inhibitors in CML Leukemic Stem Cells." Oncotarget 2017.

Salati, Simona, et al. "Deregulated Expression of MiR-29a-3p, MiR-494-3p and MiR-660-5p Affects Sensitivity to Tyrosine Kinase Inhibitors in CML Leukemic Stem Cells." Oncotarget 2017.